Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open multicenter phase 4 study of cefotaxime sodium + sulbactam sodium injection for acute bacterial respiratory and urinary tract infections
ChiCTR-ONC-11001590Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefotaxime and sulbactam sodium in bacterial airway infections and Symptomatic Bacteriuria, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: incidence. Started Aug 2011; status: completed.
02
Drugs
cefotaximesulbactam sodium
03
Conditions
bacterial airway infectionsSymptomatic Bacteriuria
Beyond the preview
Go deeper on ChiCTR-ONC-11001590.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-11001590.